UTI Healthcare Fund - G

NAV ₹122.34 ↓ -0.12 (-0.10 %) as on 7 Aug 20

(Erstwhile UTI Pharma & Healthcare Fund)

Table of Contents

Scheme Objective
NAV Price Chart
Returns
- Historical Returns
- Compounded Returns
Growth Of 10k Over Years
Holdings / Portfolio
All Plan & Options
Fund Manager Information
Custodians
Registrar & Transfer Agent (RTA)
Administrator Companies
Auditors

Scheme Objective

The Investment objective of the Scheme is capital appreciation through investments in equities and equity related instruments of the Pharma & Healthcare sectors.

UTI Healthcare Fund is a Equity - Sectoral fund launched on 28 Jun 99. It is a fund with High risk and has given a CAGR return of 14.1% since its launch. Ranked 40 in Sectoral category. Return for 2019 was 1.2% , 2018 was -7.5% and 2017 was 6.2% .

Below is the key information for UTI Healthcare Fund

NAV as on 7 Aug 20	₹122.34 ↓ -0.12 (-0.10 %)
Net Assets (AUM) as on 30 Jun 2020	₹481 Cr.
Launch Date	28 Jun 1999
Category	Equity - Sectoral
Rating	☆
Type	Open Ended Fund
Risk	High
AMC	UTI Asset Management Company Ltd

Alpha Ratio	5.51
Expense Ratio	2.77 %
Sharpe Ratio	1.054
Information Ratio	0.38
Benchmark	Not Available
Min Investment	₹5,000
Min SIP Investment	₹500
Exit Load	0-1 Years (1%),1 Years and above(NIL)

NAV Price Chart

Returns

Annual Compounded Returns

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 7 Aug 20

Duration	Returns
1 Month	16.7%
3 Month	24%
6 Month	35.7%
1 Year	56.2%
3 Year	13%
5 Year	4.4%
10 Year
15 Year
Since launch	14.1%

Historical Annual Returns

Historical performance (Yearly) on absolute basis

Year	Returns
2019	1.2%
2018	-7.5%
2017	6.2%
2016	-9.7%
2015	12.4%
2014	43.7%
2013	23.3%
2012	24.8%
2011	-9.6%

Growth of 10k Over Years

Date	Value
31 Jul 15	₹10,000
31 Jul 16	₹9,716
31 Jul 17	₹8,884
31 Jul 18	₹8,932
31 Jul 19	₹8,096
31 Jul 20	₹12,276

Asset Allocation

Asset Class	Value
Cash	1.11%
Equity	98.89%

Sector Allocation

Sector	Value
Health Care	97.48%
Basic Materials	1.41%

Top Securities Holdings / Portfolio

Holdings/Securities

Name	Global Industry	Holding	Value	Quantity
Dr Reddy's Laboratories Ltd (Healthcare) Equity, Since 28 Feb 18 \| 500124	Drug Manufacturers - Specialty & Generic	11%	₹52 Cr	132,944
Sun Pharmaceuticals Industries Ltd (Healthcare) Equity, Since 31 Oct 06 \| SUNPHARMA	Drug Manufacturers - Specialty & Generic	10%	₹50 Cr	1,051,975 ↑ 278,460
Aurobindo Pharma Ltd (Healthcare) Equity, Since 31 Oct 13 \| AUROPHARMA	Drug Manufacturers - Specialty & Generic	9%	₹41 Cr	537,031
Cipla Ltd (Healthcare) Equity, Since 31 Jan 03 \| 500087	Drug Manufacturers - General	7%	₹34 Cr	531,236 ↓ -137,172
Biocon Ltd (Healthcare) Equity, Since 31 Oct 18 \| 532523	Biotechnology	6%	₹29 Cr	745,974 ↑ 20,000
Ipca Laboratories Ltd (Healthcare) Equity, Since 31 Jan 14 \| 524494	Drug Manufacturers - Specialty & Generic	6%	₹27 Cr	161,673 ↑ 16,852
Divi's Laboratories Ltd (Healthcare) Equity, Since 30 Sep 17 \| DIVISLAB	Drug Manufacturers - Specialty & Generic	5%	₹26 Cr	113,782 ↓ -10,000
Lupin Ltd (Healthcare) Equity, Since 31 May 18 \| 500257	Drug Manufacturers - Specialty & Generic	5%	₹26 Cr	283,686 ↓ -79,387
Cadila Healthcare Ltd (Healthcare) Equity, Since 31 Jan 03 \| 532321	Drug Manufacturers - Specialty & Generic	5%	₹22 Cr	631,281 ↓ -64,377
Ajanta Pharma Ltd (Healthcare) Equity, Since 31 Jul 17 \| 532331	Drug Manufacturers - Specialty & Generic	4%	₹19 Cr	136,317

1 - 10 of 26

Ready to Invest?
Talk to our investment specialist

Fund Managers

Name	Since	Tenure
V Srivatsa	3 Mar 17	3.33 Yr.

Custodians

Company	Address
Bank of Nova Scotia	12/13, Maker Chamber VI,220, Nariman Point
Citibank N.A. India	Trent House, 3rd Floor, G Block,,Plot No.60, Next to Citibank,,Bandra Kurla Complex,,Bandra (East),
Stock Holding Corporation of India	Mittal Court, ‘B’ Wing,,Nariman Point

Registrar & Transfer Agent

KFin Technologies Private Limited
Address	"KARVY HOUSE",46, Avenue 4, Street No.1,,Banjara Hills,
FAX	91-40-23311968
Email	mailmanager@karvy.com

Administrator Companies

Company	Address
UTI Mutual Fund	UTI Tower , `GN' Block,,Bandra Kurla Complex,,Bandra (E)

Auditors

Company	Address
Haribhakti & Co. Chartered Accountants	42, Free Press House,4th Floor,,215, Nariman Point,

All Plan & Options

Fund and Plan	NAV	6 Month	1 Year	3 Year	5 Year
UTI Healthcare Fund Growth	₹122.34 ↓ -0.12	35.74 %	56.18 %	12.96 %	4.36 %
UTI Healthcare Fund Normal Dividend, Payout	₹94.5517 ↓ -0.09	35.74 %	56.18 %	12.96 %	4.36 %
UTI Healthcare Fund Normal Dividend, Reinvestment	₹94.5517 ↓ -0.09	35.74 %	56.18 %	12.96 %	4.36 %
Data as on 7 Aug 20

Disclaimer:
All efforts have been made to ensure the information provided here is accurate. However, no guarantees are made regarding correctness of data.

Shepard Technologies Pvt. Ltd : A -204, Technocity, Plot No X-4/1 & X-4/2, TTC, MIDC, Mahape, Navi Mumbai - 400710

AMFI Registration No. 112358 | CIN: U74999MH2016PTC282153

Mutual fund investments are subject to market risks. Please read the scheme information and other related documents carefully before investing. Past performance is not indicative of future returns. Please consider your specific investment requirements before choosing a fund, or designing a portfolio that suits your needs.

Shepard Technologies Pvt. Ltd. (with ARN code 112358) makes no warranties or representations, express or implied, on products offered through the platform. It accepts no liability for any damages or losses, however caused, in connection with the use of, or on the reliance of its product or related services. Terms and conditions of the website are applicable.